TARGET THERAPEUTICS TAPER GUIDE WIRE— 510(k) K864316

Substantially Equivalent

Target Therapeutics

FDA 510(k) clearance K864316 for TARGET THERAPEUTICS TAPER GUIDE WIRE, Substantially Equivalent on 1987-03-20. Applicant: Target Therapeutics.

Clearance details

Applicant: Target Therapeutics
Product code: Code DQX
Advisory panel: Cardiovascular
Date received: 1986-11-03
Decision date: 1987-03-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQX

product code DQX

Death: 298
Injury: 4,385
Malfunction: 7,203
Other: 5
Total: 11,891

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.